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Amyloida b s t r a c t
Amyloid-b, the protein implicated in Alzheimer’s disease, along with a number of other proteins, has
been shown to form amyloid ﬁbrils. Fibril forming proteins share no common primary structure and
have little known function. Furthermore, all proteins have the ability to form amyloid ﬁbrils under
certain conditions as the ﬁbrillar structure lies at the global free energy minimum of proteins. This
raises the question of the mechanism of the evolution of the amyloid ﬁbril structure. Experimental
evidence supports the hypothesis that the ﬁbril structure is a by-product of the forces of protein
folding and lies outside the bounds of evolutionary pressures.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Amyloid ﬁbrils are the end-product of a variety of different pro-
teins, notably amyloid-b, the protein implicated in Alzheimer’s dis-
ease. The aggregation of these ﬁbrils into cerebral plaques was at
one time believed to be causally linked to Alzheimer’s disease.
However, this view has largely been abandoned as recent research
has shown that small amyloid oligomers, not the ﬁbrils them-
selves, are the neurotoxic species [1]. Whether these oligomers
are kinetic precursors to ﬁbrils or form along a separate reaction
coordinate is still a matter of debate [2]. Several other proteins,
each implicated in a speciﬁc pathology, have also been shown to
form amyloid ﬁbrils. These proteins include a-synuclein (Parkin-
son’s disease), Surfactant Protein C (Pulmonary Alveolar Proteino-
sis) and tau (frontotemporal lobe dementia) [3]. Silk from silk
spiders also form amyloid ﬁbrils on their way to forming macro-
scale silk ﬁbres [4,5] and some amyloid has been shown to be func-
tional [6].
Amyloid ﬁbrils have been extensively studied since advanced
nanoscale techniques, such as atomic force microscopy (AFM),
have become commonplace in laboratories. The ﬁbril is ubiquitous
in nature: it is implicated in numerous pathologies, it is seen in the
products of ﬁne silks, and it’s beauty is captivating on a molecular
scale: beta sheets perfectly stacked together, slowly rotating about
their axis and then intertwined with one another to produce long,
slender protein structures. What makes ﬁbrils even more mysteri-
ous is that no primary structure has been identiﬁed that is associ-
ated with the amyloid ﬁbril structure.The term ‘‘amyloid’’ was introduced in 1854 by Rudolph Vir-
chow who erroneously believed these deposits consisted of cellu-
lose. (Amyloid from the Latin amylum). In 1859, Friedreich and
Kekule demonstrated that these deposits were in fact proteina-
ceous rather than carbohydrate based (reviewed by [7]). Despite
this new material evidence, the term amyloid remained in the sci-
entiﬁc literature of the day. Early microscopists showed that these
deposits stained with Congo Red showed apple-green birefrin-
gence under polarized light [8]. This test is still used as the patho-
logical standard in identifying amyloid deposits. In the early
1980’s, evidence began to mount that these amyloid plaques con-
sisted of bundles of unbranched ﬁbrillar structures ranging from 6–
13 nm in width with lengths in the order of micrometers [9]. Amy-
loid deposits were associated with a variety of neuropathology’s
including Alzheimer’s disease [10] and an amyloid forming protein,
termed amyloid-b, was shown to be associated with Alzheimer’s
disease [11,12]. By the beginning of the next decade, the amyloid
cascade hypothesis posited that the presence of amyloid ﬁbrils is
casual to the symptoms associated with Alzheimer’s disease [13].
Further studies using advanced techniques demonstrated that the
amyloid ﬁbril consists of a series of beta-sheet structures, stacked
in-register in a parallel or anti-parallel conformation with a cross-b
spine [14]. Toxicity studies have shown that amyloid ﬁbrils are
minimally toxic, but rather their on-pathway protoﬁbrils or oligo-
mers are the toxic species in neurodegenerative disorders [1,15].
This revelation has brought into question if the amyloid ﬁbril
structure has any biological relevance.
Given that oligomers, rather than mature ﬁbrils, are most likely
the toxic species in diseases such as Alzheimer’s, do these ﬁbrils
serve any biologically relevant purpose or can they be selected
for or against? Researchers such as the late Mark Smith have ar-
gued that amyloid-b is in fact neuroprotective [16]. Selkoe has
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sink absorbing toxic oligomers preventing the oligomers from
becoming neurotoxic through either their membrane destructive
pore structure or their redox properties [17]. Selkoe has made a
particularly clear layman’s analogy of amyloid plaques: plaques
are like jails for oligomers. Toxic oligomers end in amyloid jails
preventing them from doing any harm. Once the jails get full, the
oligomers are able to destroy neurons unabated. Breaking up amy-
loid ﬁbrils would be like getting rid of jails: more toxic oligomers
would be on the streets causing damage [18]. Bush has argued that
amyloid plaques (made of mature ﬁbrils) are in fact a, ‘‘last ditch
cellular attempt to wall off potentially toxic AB oligomers’’ [19].
These explanations of amyloid ﬁbrils may incidentally be true
but they imply an active function of the cell to produce ﬁbrils to
serve an evolutionary advantageous purpose. There is no evidence
that there is any cellular machinery involved in producing amyloid
ﬁbrils and therefore the cell can make no ‘‘attempts’’ to prevent its
premature apoptosis through amyloid associated mechanisms.
2. Discussion
It is a current paradigm of molecular biology that every protein
structure has a function. A protein with an evolutionary advanta-
geous function gets conserved whereas those with lesser functions
may evolve to a more advantageous function. Evolutionary pres-
sures shape the genome to produce a species ﬁt for its environ-
ment. However, recent research has called into question the
evolutionary origins and processes driving amyloid ﬁbril structure.
The amyloid ﬁbril structure is a structure available to all proteins
under certain conditions [20–22]. The amyloid ﬁbril structure
occupies the global energy minimum of every protein’s free energy
landscape indicating that it is only kinetic barriers and not thermo-
dynamic processes that prevent all proteins from forming amyloid
species – a somewhat daunting thought for life on earth [23]. How-
ever, cells have evolved mechanisms to prevent the aggregation or
ﬁbrillization of proteins [24]. Furthermore, some cells have evolved
mechanisms of harnessing amyloid which is termed functional
amyloid. However, it is the mechanisms themselves, not the amy-
loid fold itself which has recently evolved [25]. If there is no pri-
mary sequence which drives ﬁbril formation, how did the
amyloid ﬁbril structure evolve? The ﬁbrillization process is driven
by protein backbone interactions; the protein backbone being a
feature common to all proteins [26]. It is the hydrogen bonds with-
in the backbone that drive this folding (or misfolding) process [27].
It has been over 30 years since Gould presented his seminal pa-
per, ‘‘The spandrels of San Marco and the Panglossian Paradigm: a cri-
tique of the adaptionist programme’’[28]. In this classic work, Gould
eloquently describes how the beauty found in nature often mirrors
that of spandrels found in medieval Christian architecture, the
spandrel being ‘‘the tapering triangular spaces formed by the inter-
section of two rounded arches at right angles. . .Each spandrel contains
a design admirably ﬁtted into its tapering space’’ [28]. While the
attention to visitors to the church is the beauty contained within
the spandrels, it is important to remember that these spandrels
are merely ‘‘necessary architectural by-products of mounting a dome
on rounded arches’’ [28]. While the real beauty from a functional
point of view lies in the method of placing a dome on a rectangular
structure, the spandrel brings aesthetics to an otherwise plain
function. The spandrel is not an independently functioning entity.
I propose that since the amyloid ﬁbril has not evolved in a classical
manner with side chains being selected through random DNA
mutations, its structure lies outside the constraints of evolutionary
pressure. Rather, the amyloid ﬁbril is an elegant by-product of the
classical physical laws governing the interaction of all bodies
including the folding of proteins.If these are indeed the case, that all proteins can form ﬁbrils,
that the protein side-chains do not contribute to forming this sta-
ble structure, and that the ﬁbril is an intrinsic property of the pro-
tein backbone, than evolution has not selected for the amyloid fold
because of any evolutionary advantage to this structure. Rather,
evolution developed mechanisms to prevent the negative effects
of this structure (such as chaperone systems) or developed mech-
anisms to take advantage of this structure (functional amy-
loid).Despite its apparent lack of function, the amyloid fold has
persisted since antiquity with modulating mechanisms appearing
more recently [29]. Just as it is the beautiful spandrels inside a
cathedral which are a by-product of the functional arches, it stands
to reason than that amyloid structures such as ﬁbrils and func-
tional amyloid are molecular spandrels – a by-product of the phys-
ical laws of our universe and nature’s necessity to have molecular
machines do the work inside every living organism. The inherent
beauty and order contained within the amyloid structure serves
as an analytical distraction and inverts the order of analysis. Just
as the spandrels are constrained by the needs for structural integ-
rity within the dome, so too are amyloid ﬁbrils constrained by uni-
versal physical laws.
However, this elegant by-product is not useless. In fact, ﬁbrils
have high rigidity and amongst the highest tensile strength of all
materials – biological and synthetic alike [30–32]. These advanta-
geous properties have made amyloid ﬁbrils nature’s preferred
structure for silk spider webs [5]. If amyloid ﬁbrils are indeed
molecular spandrels of no conserved function, the proteins in silk
spiders responsible for using the ﬁbrillar structure to form spider
webs would be the advantageous part of the mechanism and its
structures would be selected for even though the materials used
are not.
The structure of amyloid ﬁbrils are a physical structure that lies
outside the bounds of evolutionary selection because the selection
of protein residues has no inﬂuence on their ﬁbrillar structure. The
folding of a protein backbone is not driven by evolutionary pres-
sures but by physical forces that drive interactions between all
classical bodies.
Under this paradigm, that amyloid ﬁbrils are a structural by-
product of natural laws, the amyloid ﬁbril and associated plaques
have no evolutionary conserved function. Amyloid plaques may in-
deed absorb amyloid oligomers into inert ﬁbrils to prevent neuro-
toxicity but they were not selected for this function – it is just an
advantageous by-product of their structure.
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